The 3D bioprinted human tissue market is set for rapid growth, reaching $3.59 billion by 2030 at a 13.2% CAGR, driven by regenerative medicine and advanced drug testing.
Read More2D cell culture market to reach $8.44 billion by 2030 at 9.7% CAGR, driven by growing need for high-throughput screening.
Read MoreThe Cancer Supportive Care Drugs market size is expected to reach $25.93 billion in 2030 at a CAGR of 3.7%, driven by improved cancer survival rates.
Read MoreThe Cancer Monoclonal Antibodies market size is expected to reach $166.92 billion in 2030 at a CAGR of 14.2%, driven by rising cancer incidence.
Read MoreThe Cancer Immunotherapy Drug Discovery Outsourcing market size is expected to reach $2.64 billion in 2030 at a CAGR of 9.4%, driven by high R&D costs.
Read MoreThe Cancer Immunotherapy market size is expected to reach $210.39 billion in 2030 at a CAGR of 11.1%, driven by rising cancer incidence.
Read MoreThe Cancer Clinical Decision Tools market size is expected to reach $0.88 billion in 2030 at a CAGR of 10.2%, driven by rising cancer incidence.
Read MoreThe Cancer Biologics market size is expected to reach $203.29 billion in 2030 at a CAGR of 9.6%, driven by rising prevalence of chronic diseases.
Read MoreThe Cancer Antibody Drug Conjugates market size is expected to reach $15.77 billion in 2030 at a CAGR of 11.4%, driven by rising prevalence of cancer.
Read MoreThe Calorie Supplements market size is expected to reach $2.08 billion in 2030 at a CAGR of 9.5%, driven by growing need for dietary supplements.
Read More